8912
A.M. Tomkiel et al. / Tetrahedron 69 (2013) 8904e8913
(CH2), 23.8 (CH2), 22.8 (CH3), 22.7 (CH2), 22.6 (CH3), 21.1 (CH3), 20.1
(CH3), 18.7 (CH3), 14.3 (CH2), 12.2 (CH3); EIMS, m/z: 492 (Mþ, 4%),
369 [(Mꢁp-CH3C6H4S)þ, 100%]; elemental analysis calcd (%) for
C34H52S: C 82.86, H 10.63, S 6.51; found: C 82.57, H 10.66, S 6.53.
(10,20:30,40-di-O-isopropylidene- -galactopyranos-60-yl)-cholest-
a-D
5-ene (4; 117 mg, 52%), followed by cholesterol (6; 10 mg, 7%)
eluted with hexaneeethyl acetate (9:1).
4.4.1. 3b a-D
-O-(10,20:30,40-Di-O-isopropylidene- -galactopyranos-60-
yl)-cholest-5-ene (4).35 Colorless crystals; Rf¼0.35 (AcOEt/hexane
4.3.1.2. 6
b-p-Tolylsulfanyl-3a,5a-cyclo-25R-spirostane
1:9); mp 128e131 ꢂC (hexane); [
a
]
20 ꢁ63.7 (c 1.0, CHCl3); IR, nmax
:
(17). Colorless crystals; Rf¼0.49 (AcOEt/hexane 5:95); mp
D
20
118e121 ꢂC (hexane); [
a
]
ꢁ86.6 (c 1.0, CHCl3); IR, nmax: 3063,
1070 cmꢁ1; 1H NMR,
d
(ppm): 5.53 (d, 1H, J¼5.0 Hz, H-10), 5.34 (m,
D
1492, 1456, 1096, 1049, 898, 813 cmꢁ1
;
1H NMR,
d (ppm): 7.29 (d,
1H, H-6), 4.60 (dd, 1H, J1¼7.9 Hz, J2¼2.3 Hz, H-30), 4.30 (dd, 1H,
J1¼5.3 Hz, J2¼2.3 Hz, H-20), 4.28 (dd, 1H, J1¼8.1 Hz, J2¼1.8 Hz, H-40),
3.92 (dt, 1H, J1¼6.3 Hz, J2¼1.7 Hz, H-50), 3.68 (dd, 1H, J1¼10.1 Hz,
J2¼6.3 Hz, H-60a), 3.62 (dd, 1H, J1¼10.1 Hz, J2¼6.5 Hz, H-60b), 3.21
2H, J¼8.1 Hz, HeAr), 7.08 (d, 2H, J¼8.1 Hz, HeAr), 4.39 (m, 1H, H-
16), 3.48 (m, 1H, H-26a), 3.37 (t, 1H, J¼10.9 Hz, H-26b), 2.80 (dd, 1H,
J1¼3.6 Hz, J2¼2.4 Hz, H-6
a), 2.33 (s, 3H, H-Ar-CH3), 1.13 (s, 3H, H-
19), 0.99 (d, 3H, J¼7.0 Hz, H-21), 0.90 (s, 3H, H-18), 0.80 (d, 3H,
J¼6.4 Hz, H-27), 0.69 (dd, 1H, J1¼5.2 Hz, J2¼4.3 Hz, H-4a), 0.47 (dd,
(m, 1H, H-3a), 1.54 (s, 3H, H-isopropylidene), 1.45 (s, 3H, H-iso-
propylidene), 1.35 (s, 3H, Heisopropylidene), 1.33 (s, 3H,
Heisopropylidene), 1.00 (s, 3H, H-19), 0.92 (d, 3H, J¼6.6 Hz, H-21),
0.870 (d, 3H, J¼6.6 Hz, H-26 or H-27), 0.866 (d, 3H, J¼6.6 Hz, H-26
1H, J1¼8.0 Hz, J2¼5.2 Hz, H-4b); 13C NMR,
d (ppm): 137.1 (C), 133.6
(CH), 132.9 (C), 129.6 (CH), 109.3 (C), 80.8 (CH), 66.9 (CH2), 62.3
(CH), 55.8 (CH), 55.1 (CH), 47.9 (CH), 43.3 (C), 41.7 (CH), 40.8 (C),
40.2 (CH2), 36.7 (C), 35.2 (CH2), 33.6 (CH2), 31.8 (CH2), 31.4 (CH2),
30.3 (CH), 30.0 (CH), 28.8 (CH2), 28.6 (CH), 25.3 (CH2), 22.5 (CH2),
21.1 (CH3), 20.2 (CH3), 17.1 (CH3), 16.7 (CH3), 14.5 (CH3), 14.4 (CH2);
EIMS, m/z: 520 (Mþ, 21%), 397 [(Mꢁp-CH3C6H4S)þ, 100%]; HRMS
(EI): m/z calcd for C34H48O2S: 520.3375; found 520.3393.
or H-27), 0.68 (s, 3H, H-18); 13C NMR,
d (ppm): 141.0 (C), 121.4 (CH),
109.0 (C), 108.4 (C), 96.3 (CH), 79.7 (CH), 71.1 (CH), 70.63 (CH), 70.58
(CH), 67.0 (CH), 66.7 (CH2), 56.7 (CH), 56.1 (CH), 50.1 (CH), 42.3 (C),
39.7 (CH2), 39.5 (CH2), 39.0 (CH2), 37.2 (CH2), 36.8 (C), 36.1 (CH2),
35.7 (CH), 31.9 (CH2), 31.8 (CH), 28.4 (CH2), 28.2 (CH2), 27.9 (CH),
26.1 (CH3), 26.0 (CH3), 24.9 (CH3), 24.4 (CH3), 24.2 (CH2), 23.8 (CH2),
22.8 (CH3), 22.5 (CH3), 21.0 (CH2), 19.3 (CH3), 18.7 (CH3), 11.8 (CH3);
EIMS, m/z: 628 [Mþ, <1%], 368 [(Mꢁ1,2:3,4-di-O-isopropylidene-
4.3.1.3. Methyl
Colorless oil; Rf¼0.55 (AcOEt/hexane 1:9); [
CHCl3); IR, nmax: 1731,1492, 1438,1103, 812 cmꢁ1; 1H NMR,
6b-p-tolylsulfanyl-3a,5a-cyclocholanoate (21).
20
a-D
-galactopyranose)þ, 100%]; elemental analysis calcd (%) for
a
]
ꢁ35.3 (c 1.0,
D
d
(ppm):
C39H64O6: C 74.48, H 10.26; found: 74.32, H 10.23.
7.28 (d, 2H, J¼7.9 Hz, HeAr), 7.08 (d, 2H, J¼7.9 Hz, HeAr), 3.67 (s,
3H, Hemethyl ester), 2.82 (m, 1H, H-6), 2.32 (s, 3H, HeAreCH3),
1.12 (s, 3H, H-19), 0.94 (d, 3H, J¼6.5 Hz, H-21), 0.78 (s, 3H, H-18),
0.67 (dd, 1H, J1¼5.4 Hz, J2¼4.5 Hz, H-4a), 0.42 (dd, 1H, J1¼7.8 Hz,
4.4.2. 6
yl)-3 ,5
1:9); [
b a-D
-O-(10,20:30,40-Di-O-isopropylidene- -galactopyranos-60-
a
a
-cyclocholestane (5). White solid; Rf¼0.40 (AcOEt/hexane
a
]
20 ꢁ17.3 (c 0.1, CHCl3); IR, nmax: 1070; 1H NMR,
d (ppm): 5.52
D
J2¼5.4 Hz, H-4b); 13C NMR,
d (ppm): 174.7 (C), 136.7 (C), 133.2 (C),
(d, 1H, J¼5.0 Hz, H-10), 4.60 (dd, 1H, J1¼8.0 Hz, J2¼2.2 Hz, H-30), 4.35
(dd, 1H, J1¼8.1 Hz, J2¼1.7 Hz, H-40), 4.30 (dd, 1H, J1¼5.0 Hz,
J2¼2.3 Hz, H-20), 3.95 (m,1H, H-50), 3.62 (t,1H, J¼8.5 Hz, H-60a), 3.46
(dd, 1H, J1¼8.8 Hz, J2¼5.7 Hz, H-60b), 2.91 (m, 1H, H-6), 1.56 (s, 3H,
Heisopropylidene), 1.45 (s, 3H, Heisopropylidene), 1.35 (s, 6H,
Heisopropylidene), 1.00 (s, 3H, H-19), 0.92 (d, 3H, J¼6.5 Hz, H-21),
0.880 (d, 3H, J¼6.6 Hz, H-26 or H-27), 0.875 (d, 3H, J¼6.6 Hz, H-26
or H-27), 0.72 (s, 3H, H-18), 0.58 (dd, 1H, J1¼4.9 Hz, J2¼4.2 Hz, H-
133.0 (CH), 129.5 (CH), 55.90 (CH), 55.89 (CH), 54.9 (CH), 51.4 (CH3),
47.8 (CH), 43.1 (C), 42.7 (C), 40.1 (CH2), 36.8 (C), 35.4 (CH), 35.3
(CH2), 33.6 (CH2), 31.02 (CH2), 30.96 (CH2), 30.4 (CH), 28.5 (CH), 28.1
(CH2), 25.3 (CH2), 24.2 (CH2), 22.7 (CH2), 21.0 (CH3), 20.1 (CH3), 18.2
(CH3), 14.2 (CH2), 12.2 (CH3); ESI MS, m/z: 1011 [(2MþNa)þ, 5%], 548
[(MNaþMeOH)þ, 30%], 517 (MNaþ, 100%); HRMS (ESI): m/z calcd for
(C32H46O2SNa)þ: 517.3116; found 517.3108.
4a), 0.40 (dd, 1H, J1¼7.8 Hz, J2¼4.9 Hz, H-4b); 13C NMR,
d (ppm):
4.4. Electrolysis of 6b-p-tolylsulfanyl-3a,5a-cyclocholestane
(2b) in the presence of 1,2:3,4-di-O-isopropylidene-D-gal-
actopyranose (3)
108.8 (C), 108.4 (C), 96.3 (CH), 80.7 (CH), 71.0 (CH), 70.9 (CH), 70.5
(CH), 66.8 (CH), 65.9 (CH2), 56.5 (CH), 56.4 (CH), 48.0 (CH), 43.3 (C),
42.8 (C), 40.4 (CH2), 39.6 (CH2), 36.4 (C), 36.2 (CH2), 35.9 (CH), 34.4
(CH2), 33.3 (CH2), 30.2 (CH), 28.3 (CH2), 28.0 (CH), 26.1 (CH3), 26.0
(CH3), 25.1 (CH2), 25.0 (CH3), 24.4 (CH3), 24.2 (CH2), 23.9 (CH2),
22.82 (CH3), 22.79 (CH2), 22.6 (CH3), 22.2 (CH), 19.4 (CH3), 18.7
(CH3), 12.9 (CH2), 12.3 (CH3); ESI MS, m/z: 651 (MNaþ, 100%); HRMS
(ESI): m/z calcd for C39H64O6Naþ: 651.4601; found 651.4614.
6
b
-p-Tolylsulfanyl-3
a
,5
a
-cyclocholestane (2b; 176 mg; 0.36
-galactopyranose (3;
mmol) and 1,2,3:4-di-O-isopropylidene-
D
93 mg; 0.36 mmol) were dissolved in a 0.1 M solution of tetrabu-
tylammonium tetrafluoroborate in dichloromethane (3.5 mL) and
introduced into the anodic compartment together with a 0.3 g of 3A
molecular sieve to eliminate traces of water. The same supporting
electrolyte was placed in the cathodic compartment with an
anionite (1 g, Dowex 2x8, 200e400 mesh, perchlorate form) added
to eliminate chloride ions from forming by the reduction of
dichloromethane. A preparative electrolysis was carried out in
a divided H-cell in which the cathodic and anodic compartments
(3.5 mL of electrolytes each) were separated by a glass frit under
galvanostatic conditions. A direct current 7.5 mA was run for
4000 s. A platinum mesh was used as a cathode and a platinum
plate (2ꢃ1.5 cm) was used as an anode. Ag/0.1 M AgNO3 in an
acetonitrile electrode was used as a reference. When the electrol-
ysis was completed the solvent was removed from the reaction
mixture and products were separated by silica gel column chro-
4.4.3. Other glycoconjugates obtained as products of the electro-
chemical reactions
4.4.3.1. 3b a-D-glucofuranos-
-O-(10,20:50,60-Di-O-cyclohexylidene-
30-yl)-cholest-5-ene (14). Colorless crystals; Rf¼0.53 (AcOEt/hexane
15:85); mp 49e52 ꢂC (hexane); [
a
]
D
20 ꢁ17.4 (c 0.25, CHCl3); IR, nmax
:
1077 cmꢁ1; 1H NMR,
d
(ppm): 5.89 (d, 1H, J¼3.6 Hz, H-10), 5.34 (m,
1H, H-6), 4.46 (d, 1H, J¼3.6 Hz, H-20), 4.30 (m, 1H, H-50), 4.10 (m, 2H,
H-60a, H-40), 4.04 (d, 1H, J¼3.1 Hz, H-30), 3.95 (dd, 1H, J1¼8.4 Hz,
J2¼6.1 Hz, H-60b), 3.36 (m, 1H, H-3
a), 1.01 (s, 3H, H-19), 0.92 (d, 3H,
J¼6.5 Hz, H-21), 0.88 (d, 3H, J¼6.6 Hz, H-26 or H-27), 0.87 (d, 3H,
J¼6.6 Hz, H-26 or H-27), 0.69 (s, 3H, H-18); 13C NMR,
d (ppm): 140.7
(C), 121.8 (CH), 112.4 (C), 109.4 (C), 105.0 (CH), 83.6 (CH), 81.4 (CH),
80.1 (CH), 79.6 (CH), 72.2 (CH), 67.2 (CH2), 56.8 (CH), 56.2 (CH), 50.2
(CH), 42.3 (C), 39.8 (CH2), 39.5 (CH2), 38.9 (CH2), 37.3 (CH2), 36.8 (C),
36.51 (CH2), 36.48 (CH2), 36.2 (CH2), 35.78 (CH), 35.76 (CH2), 34.9
(CH2), 32.0 (CH2), 31.9 (CH), 29.3 (CH2), 28.2 (CH2), 28.0 (CH), 25.2
(CH2), 24.9 (CH2), 24.3 (CH2), 24.1 (CH2), 23.91 (CH2), 23.89 (CH2),
matography. The hexane elution afforded
nylcholest-5-ene (1b; 38 mg; 22%). With the hexaneeethyl acetate
mixture (95:5) -gal-
-O-(10,20:30,40-di-O-isopropylidene-
actopyranos-60-yl)-3
-cyclocholestane (5; 2 mg; 1%) was eluted.
Further elution with hexaneeethyl acetate (93:7) afforded 3 -O-
3b-p-tolylsulfa-
6b
a-D
a,5a
b